Thursday, May 20, 2021

11:00 – 11:30am    Welcome and Overview – M. L. Mathre, RN, MSN & Mikhail Kogan, MD

11:30 – 1:10 pm     State of Cannabis Laws and Regulations - The Invisible Patient

11:30 – 11:55 am    The Broad Scope of Patient Needs - Jon Gettman, PhD

11:55 – 12:20 pm    Minorities and Veterans – Brandon Wyatt, Esq

12:20 – 12:45 pm    Reclassification of Cannabis in the Single Convention Drug Control Treaty Pursuant to Critical Review Process of World Health Organization’s Expert Committee on Drug Dependence: Implications for Policy, Patient Access, and the Cannabis Industry Inside the US - Michael Krawitz

12:45 – 1:10 pm      Live Q & A with faculty

1:10 – 1:15  Break

1:15 – 2:50              State of Cannabis Research – Catch 22

1:15 – 1:33 pm        Early Attempts at Cannabis Research – Melanie Dreher, PhD, RN

1:33 – 1:51 pm        Is the End of the University of Mississippi’s Monopoly in Sight? – Sue Sisley, MD with Shane Pennington and Matt Zorn

1:52 – 2:10 pm        Four Years after the 2017 NASEM report on The Health Effects of Cannabis and Cannabinoids: What We’ve Learned and Where We’re Headed – Ziva Cooper, PhD

2:11 – 2:29 pm        Research Interests of the National Center for Complimentary and Integrative Health – David Shurtleff, PhD

2:30– 2:50 pm         Live Q & A with faculty

2:50 – 3:00 pm       Break

3:00 – 4:30 pm       State of Cannabis Education – Who is Teaching Who?

3:00 – 3:15 pm        Nursing survey - Yolanda Nitti, RN, PhD

3:15 – 3:30 pm        MD University Cannabis program - Leah Sera, PharmD

3:30 – 4:00 pm        Core Steps Toward Developing Competencies for Medical Cannabis Education in Medical Schools - Mikhail Kogan, MD, Yuval (Tuby) Zolotov, PhD, Leslie Mendoza Temple, MD, Abraham Benavides, MD

4:00 – 4:30 pm        Q & A with faculty

Friday, May 21, 202

11:00 – 5:00 pm     State of the Science - What We Do Know About the ECS and Cannabis

11:00 – 11:45am     Overview:  What We do Know About the ECS and Cannabis -   Greg Gerdeman, PhD

11:45 – 12:30 pm    Matters of MIND: Examining the Impact of Medical Cannabis –  Staci Gruber, PhD

12:30 – 12:40 pm    Break

12:40 - 1:20 pm       Cannabis as an Orchestra of Components for a Multitude of Conditions - David (Dedi) Meiri, PhD

1:20 – 2:00 pm        Mechanism of Action of CBD & Other Cannabinoids –  Bonni Goldstein, MD

2:00 – 2:40 pm        State of Product Safety – Jahan Marcu, PhD

2:40 – 2:55 pm        Break

2:55 – 3:40 pm        The Endocannabinoid System, Cannabis, and the Microbiome – Ethan Russo, MD

3:40 – 4:20 pm        Medicinal Plants: Missing Insights on Pharmacology - Kevin Spelman, PhD

4:20 – 5:00 pm        Q & A – State of the Science Faculty

Saturday, May 22, 202

11:00 – 5:00pm   State of Clinical Practice – Science Takes Hold

11:00 – 11:10 am    Welcome and Announcements

11:10– 11:50 pm     Challenges, Successes and New Challenges - Dustin Sulak, DO

11:50 – 12:05 pm    Cannabis Preferences by a Cohort of Veterans in Hawaii - Me Fuimanono-Poe, FNP-BC

12:05 – 12:25 pm    2019 Veterans Health and Medical Cannabis Study – Marion McNabb, PhD

12:25 – 12:35 pm    Break

12:35 – 1:15 pm      Cannabis and Women’s Health Conditions – Genester Wilson-King, MD

1:15 – 1:45 pm Pediatric Case Presentations – Rylie Maedler and Coltyn Turner (Crohn’s disease)

1:45 -2:15 pm What About the Children? – Patricia Frye, MD

2:15 – 2:45 pm Cannabis Therapeutics for the Geriatric Population - Mikhail Kogan, MD

2:45 – 2:50 pm        Break

2:50 – 3:20 pm        COVID-19 and Medical Cannabis Patients and Consumer Study – Marion McNabb, DrPH, MPH

3:20 – 4:10 pm        CBD for the Treatment of Diabetic Neuropathic Pain – Deb Kimless, MD

4:10 – 5:00 pm        Live Q & A – State of Clinical Practice faculty